The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene Promoters
Open accessAbstract
Alterations in GABAergic mRNA expression play a key role for prefrontal dysfunction in schizophrenia and other neurodevelopmental disease. Here, we show that histone H3-lysine 4 methylation, a chromatin mark associated with the transcriptional process, progressively increased at GAD1 and other GABAergic gene promoters ( GAD2 , NPY , SST ) in human prefrontal cortex (PFC) from prenatal to peripubertal ages and throughout adulthood. Alterations in schizophrenia included decreased GAD1 expression and H3K4-trimethylation, predominantly in females and in conjunction with a risk haplotype at the 5′ end of GAD1 . Heterozygosity for a truncated, lacZ knock-in allele of mixed-lineage leukemia 1 ( Mll1 ), a histone methyltransferase expressed in GABAergic and other cortical neurons, resulted in decreased H3K4 methylation at GABAergic gene promoters. In contrast, Gad1 H3K4 (tri)methylation and Mll1 occupancy was increased in cerebral cortex of mice after treatment with the atypical antipsychotic, clozapine. These effects were not mimicked by haloperidol or genetic ablation of dopamine D 2 and D 3 receptors, suggesting that blockade of D 2 -like signaling is not sufficient for clozapine-induced histone methylation. Therefore, chromatin remodeling mechanisms at GABAergic gene promoters, including MLL1-mediated histone methylation, operate throughout an extended period of normal human PFC development and play a role in the neurobiology of schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the role of this process in establishing active promoters38, it appears likely that the dysregulation of histone methylation may have downstream effects with the potential to disrupt neurodevelopment and coordinated gene expression, as animal studies have demonstrated39.”
From Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) · cites this paper as [39]
Citations
Cites
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 1×
“Next, we monitored levels of H3K4me3, and of H3-mono-methyl-lysine 4 (H3K4me1) [a related modification that partially overlaps with H3K4me3 in genome-wide screens (Heintzman et al., 2007)] around GAD1 TSS during the course of PFC development.”
MethodGenomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse
Bernstein, B., Kamal, M., Lindblad‐Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., Gingeras, T., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.001 · Cited by 1,567
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D. Y., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,071
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Self-citationAltered Hox expression and segmental identity in Mll-mutant mice
Yu, B., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 872
Histone H3 lysine 4 methylation patterns in higher eukaryotic genes
Schneider, R., Bannister, A. J., Myers, F. A., Thorne, A. W., Crane‐Robinson, C., & Kouzarides, T. (2003) · Nature Cell Biology · doi:10.1038/ncb1076 · Cited by 807
Histone lysine methylation: a signature for chromatin function
Sims, R. J., Nishioka, K., & Reinberg, D. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.007 · Cited by 708
Lieberman, J., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 608
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 352
Bharadwaj, R. A., Jiang, Y., Mao, W., Jakovcevski, M., Dincer, A., Krueger, W. H., Garbett, K. A., Whittle, C., Tushir, J. S., Liu, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1252-13.2013 · Cited by 67
Self-citationPharmacology of epigenetics in brain disorders
Narayan, P. J., & Dragunow, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67
KMT2A: Umbrella Gene for Multiple Diseases
Castiglioni, S., Fede, E. D., Bernardelli, C., Lettieri, A., Parodi, C., Grazioli, P., Colombo, E. A., Ancona, S., Milani, D., Ottaviano, E., et al. (2022) · Genes · doi:10.3390/genes13030514 · Cited by 67
Deficits in the automatic activation of religious concepts in patients with Parkinson’s disease
Butler, P. M., McNamara, P., & Durso, R. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709991202 · Cited by 66
Büttner, N., Johnsen, S. A., Kügler, S., & Vogel, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912041107 · Cited by 66
Gavin, D. P., Rosen, C., Chase, K. A., Grayson, D. R., Tun, N., & Sharma, R. P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0932 · Cited by 63
Costa, E., Chen, Y., Dong, E., Grayson, D. R., Kundaković, M., Maloku, E., Ruzicka, W. B., Satta, R., Veldić, M., Zhubi, A., et al. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.1.87 · Cited by 62
Mitchell, A., Jiang, Y., Peter, C. J., & Akbarian, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.020 · Cited by 65
Self-citationTyler, C. R., Hafez, A. K., Solomon, E. R., & Allan, A. M. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.013 · Cited by 60
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
Song, Y., Zhang, H., Yang, X., Shi, Y., & Yu, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114042 · Cited by 60
Hodjat, M., Rahmani, S., Khan, F., Niaz, K., Nigjeh, M. N., Nejad, S. M., & Abdollahi, M. R. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1979-9 · Cited by 62
Akbarian, S. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_38 · Cited by 58
Self-citationThe Genome in Three Dimensions: A New Frontier in Human Brain Research
Mitchell, A., Bharadwaj, R. A., Whittle, C., Krueger, W. H., Mirnics, K., Hurd, Y. L., Rasmussen, T. P., & Akbarian, S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.015 · Cited by 58
Self-citationMarkedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia
Rocco, B. R., Lewis, D. A., & Fish, K. N. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.022 · Cited by 61
Epigenetic regulation in memory and cognitive disorders
Rudenko, A., & Tsai, L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.034 · Cited by 58
Glausier, J. R., Kimoto, S., Fish, K. N., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.010 · Cited by 53
Cell type–specific mechanism of Setd1a heterozygosity in schizophrenia pathogenesis
Chen, R., Liu, Y., Djekidel, M. N., Chen, W., Bhattacherjee, A., Chen, Z., Scolnick, E. M., & Zhang, Y. (2022) · Science Advances · doi:10.1126/sciadv.abm1077 · Cited by 56
Why schizophrenia genetics needs epigenetics: a review.
Marić, N. P., & Švrakić, D. M. (2012) · PubMed · Cited by 53
Matsuda, S., Baba, R., Oki, H., Morimoto, S., Toyofuku, M., Igaki, S., Kamada, Y., Iwasaki, S., Matsumiya, K., Hibino, R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0300-9 · Cited by 53
Blaze, J., Asok, A., & Roth, T. L. (2015) · Stress · doi:10.3109/10253890.2015.1071790 · Cited by 52
Cruz, D. A., Lovallo, E., Stockton, S. D., Rasband, M. N., & Lewis, D. A. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22006 · Cited by 51
Hasan, A., Mitchell, A., Schneider, A., Halene, T. B., & Akbarian, S. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0395-2 · Cited by 52
Self-citationAltered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia
Kimoto, S., Zaki, M. M., Bazmi, H. H., & Lewis, D. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0533 · Cited by 53
How the epigenome contributes to the development of psychiatric disorders
Bredy, T. W., Sun, Y. E., & Kobor, M. S. (2010) · Developmental Psychobiology · doi:10.1002/dev.20424 · Cited by 51
Maćkowiak, M., Bator, E., Latusz, J., Mordalska, P., & Wędzony, K. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.013 · Cited by 50
Cortical Opioid Markers in Schizophrenia and across Postnatal Development
Volk, D. W., Radchenkova, P., Er, W., Sengupta, E. J., & Lewis, D. A. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr202 · Cited by 51
Kundaković, M., Jiang, Y., Kavanagh, D. H., Dincer, A., Brown, L. M., Pothula, V., Zharovsky, E., Park, R., Jacobov, R., Magro, I. L., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.1048 · Cited by 50
Self-citationPrefrontal Cortical Dysfunction After Overexpression of Histone Deacetylase 1
Jakovcevski, M., Bharadwaj, R. A., Straubhaar, J., Gao, G., Gavin, D. P., Jakovčevski, I., Mitchell, A., & Akbarian, S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.020 · Cited by 50
Self-citationCognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention
Wang, Y., Meng, W., Liu, Z., An, Q., & Hu, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1046692 · Cited by 51
Side of Onset in Parkinson’s Disease and Alterations in Religiosity: Novel Behavioral Phenotypes
Butler, P. M., McNamara, P., & Durso, R. (2011) · Behavioural Neurology · doi:10.1155/2011/493013 · Cited by 48
Association of histone deacetylase genes with schizophrenia in Korean population
Kim, T., Park, J. K., Kim, H., Chung, J., & Kim, J. W. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.007 · Cited by 47
Emerging roles of epigenetic mechanisms in Parkinson’s disease
Habibi, E., Masoudi‐Nejad, A., Abdolmaleky, H. M., & Haggarty, S. J. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0246-z · Cited by 48
Bator, E., Latusz, J., Wȩdzony, K., & Maćkowiak, M. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.013 · Cited by 44
Association between SNPs and gene expression in multiple regions of the human brain
Kim, S. Y., Cho, H., Lee, D., & Webster, M. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.42 · Cited by 46
Self-citationEpigenetic and Pharmacoepigenomic Studies of Major Psychoses and Potentials for Therapeutics
Abdolmaleky, H. M., Zhou, J., Thiagalingam, S., & Smith, C. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1809 · Cited by 45
Advancing Neuroscience Through Epigenetics: Molecular Mechanisms of Learning and Memory
Molfese, D. L. (2011) · Developmental Neuropsychology · doi:10.1080/87565641.2011.606395 · Cited by 45
The molecular pathology of schizophrenia—Focus on histone and DNA modifications
Akbarian, S. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.018 · Cited by 45
Self-citationTipping the lysine methylation balance in disease
Black, J. C., & Whetstine, J. R. (2012) · Biopolymers · doi:10.1002/bip.22136 · Cited by 47
Morishita, H., Kundakovic, M., Bicks, L., Mitchell, A., & Akbarian, S. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.03.005 · Cited by 42
Self-citationGavin, D. P., & Akbarian, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.008 · Cited by 42
Self-citationChen, Y., Dong, E., & Grayson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.017 · Cited by 42
Histone Methylation in the Nervous System: Functions and Dysfunctions
Pattaroni, C., & Jacob, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8376-4 · Cited by 41
Micale, V., Bartolomeo, M. D., Martino, S. D., Štark, T., Dell’Osso, B. M., Drago, F., & D’Addario, C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108279 · Cited by 41
Fish, K. N., Rocco, B. R., DeDionisio, A. M., Dienel, S. J., Sweet, R. A., & Lewis, D. A. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.009 · Cited by 41
Farrelly, L. A., Zheng, S., Schrode, N., Topol, A., Bhanu, N. V., Bastle, R. M., Ramakrishnan, A., Chan, J. C., Cetin, B., Flaherty, E. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29922-0 · Cited by 38
Hypothèse épigénétique de la schizophrénie : revue de la littérature
Rivollier, F., Lotersztajn, L., Chaumette, B., Krebs, M., & Kébir, O. (2014) · L Encéphale · doi:10.1016/j.encep.2014.06.005 · Cited by 36
An Overview of the Molecular Basis of Epigenetics
Sweatt, J. D., Nestler, E. J., Meaney, M. J., & Akbarian, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391494-1.00001-x · Cited by 41
Self-citationPusalkar, M., Suri, D., Kelkar, A., Bhattacharya, A., Galande, S., & Vaidya, V. A. (2015) · Developmental Psychobiology · doi:10.1002/dev.21365 · Cited by 36
The epigenome and postnatal environmental influences in psychotic disorders
Pishva, E., Kenis, G., van den Hove, D., Lesch, K., Boks, M. P., van Os, J., & Rutten, B. P. F. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0831-2 · Cited by 36
Epigenetic regulation of neurotransmitter signaling in neurological disorders
Wu, T., Cai, W., & Chen, X. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106232 · Cited by 33
Histone Posttranslational Modifications in Schizophrenia
Thomas, E. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_13 · Cited by 34
Lui, C., Hsu, M., Kuo, H., Chen, C.-C., Sheen, J., Yu, H., Tiao, M., Tain, Y., Chang, K., & Huang, L. (2015) · Developmental Neuroscience · doi:10.1159/000368768 · Cited by 32
Alzheimer's Disease: The Quest to Understand Complexity
Marques, S., Oliveira, C. R., Outeiro, T. F., & Pereira, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100303 · Cited by 30
Reversible histone methylation regulates brain gene expression and behavior
Xu, J., & Andreassi, M. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.08.019 · Cited by 32
Inhibition of H3K4me2 Demethylation Protects Auditory Hair Cells from Neomycin-Induced Apoptosis
He, Y., Yu, H., Cai, C., Sun, S., Chai, R., & Li, H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8841-3 · Cited by 30
Methylated Spirits: Epigenetic Hypotheses of Psychiatric Disorders
Stahl, S. M. (2010) · CNS Spectrums · doi:10.1017/s1092852900000055 · Cited by 30
The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats
Sandner, G., Host, L., Angst, M.-J., Guiberteau, T., Guignard, B., & Zwiller, J. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00153 · Cited by 29
Zhuang, K., Huang, C., Leng, L., Zheng, H., Gao, Y., Chen, G., Ji, Z., Sun, H., Hu, Y., Wu, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.055 · Cited by 31
Epigenetic Regulatory Mechanisms in Stress-Induced Behavior
Chakravarty, S., Pathak, S. S., Maitra, S., Khandelwal, N., Karisetty, B. C., & Kumar, A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801311-3.00004-4 · Cited by 32
Gillespie, B., Panthi, S., Sundram, S., & Hill, R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105488 · Cited by 32
Epigenetic Profiling in Schizophrenia and Major Mental Disorders
Iwamoto, K., & Kato, T. (2009) · Neuropsychobiology · doi:10.1159/000234811 · Cited by 28
Hattori, Y., Matsumoto, S., Morimoto, S., Daini, M., Toyofuku, M., Matsuda, S., Baba, R., Murakami, K., Iwatani, M., Oki, H., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114522 · Cited by 30
Plazas-Mayorca, M. D., & Vrana, K. E. (2010) · Journal of Proteome Research · doi:10.1021/pr100463y · Cited by 27
Reprogramming of the epigenome in neurodevelopmental disorders
Wilson, K., Porter, E. G. P., & Garcia, B. A. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1979457 · Cited by 27
Epigenetic Modifications, Alcoholic Brain and Potential Drug Targets
Jangra, A., Sriram, C. S., Pandey, S. N., Choubey, P., Rajput, P., Saroha, B., Bezbaruah, B. K., & Lahkar, M. (2016) · Annals of Neurosciences · doi:10.1159/000449486 · Cited by 28
Neuroepigenetics of Schizophrenia
Punzi, G., Bharadwaj, R. A., & Ursini, G. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.04.010 · Cited by 27
Brocos‐Mosquera, I., Miranda-Azpiazu, P., Muguruza, C., Corzo-Monje, V., Morentín, B., Meana, J. J., Callado, L. F., & Rivero, G. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01762-4 · Cited by 26
WNK Signaling Is Involved in Neural Development via Lhx8/Awh Expression
Sato, A., & Shibuyà, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055301 · Cited by 26
Smith, K. M., Maragnoli, M. E., Phull, P. M., Tran, K. M., Choubey, L., & Vaccarino, F. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103696 · Cited by 26
Marques, D., Vaziri, N., Greenway, S. C., & Bousman, C. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02735-x · Cited by 25
Magri, C., Giacopuzzi, E., Via, L. L., Bonini, D., Ravasio, V., Elhussiny, M. E. A., Orizio, F., Gangemi, F., Valsecchi, P., Bresciani, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33924-8 · Cited by 25
Epigenetic management of major psychosis
Peedicayil, J. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0038-2 · Cited by 24
Subburaju, S., Coleman, A. J., Ruzicka, W. B., & Benes, F. M. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.224 · Cited by 25
Dong, E., Locci, V., Gatta, E., Grayson, D., & Guidotti, A. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113415 · Cited by 21
The Future of Neuroepigenetics in the Human Brain
Mitchell, A., Roussos, P., Peter, C. J., Tsankova, N. M., & Akbarian, S. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00008-5 · Cited by 24
Self-citationSchizophrenia risk genes: Implications for future drug development and discovery
O’Connell, G., Lawrie, S. M., McIntosh, A. M., & Hall, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.009 · Cited by 24
Maćkowiak, M., Latusz, J., Głowacka, U., Bator, E., & Bilecki, W. (2018) · Metabolic brain disease · doi:10.1007/s11011-018-0359-3 · Cited by 19
Velmans, C., O’Donnell‐Luria, A., Argilli, E., Mau‐Them, F. T., Vitobello, A., Chan, M. C. Y., Fung, J. L. F., Rech, M., Abicht, A., Aubert‐Mucca, M., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107470 · Cited by 25
Li, M., Xiao, L., & Chen, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.823708 · Cited by 24
Environmental Regulation Of The Neural Epigenome
Sng, J., & Meaney, M. J. (2009) · Epigenomics · doi:10.2217/epi.09.21 · Cited by 24
Delphin, N., Aust, C. E., Griffiths, L. R., & Fernandez, F. (2024) · Genes · doi:10.3390/genes15030272 · Cited by 24
Gene expression in superior temporal cortex of schizophrenia patients
Sellmann, C., Pildaín, L. V., Schmitt, A., Leonardi‐Essmann, F., Durrenberger, P. F., Spanagel, R., Arzberger, T., Kretzschmar, H. A., Zink, M., Gruber, O., et al. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0473-5 · Cited by 22
Bator, E., Latusz, J., Radaszkiewicz, A., Wędzony, K., & Maćkowiak, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.04.004 · Cited by 22
Georgiev, D. D., Yoshihara, T., Kawabata, R., Matsubara, T., Tsubomoto, M., Minabe, Y., Lewis, D. A., & Hashimoto, T. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw022 · Cited by 23
Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia
Bilecki, W., & Maćkowiak, M. (2023) · Genes · doi:10.3390/genes14020243 · Cited by 23
The Role of GABA Pathway Components in Pathogenesis of Neurodevelopmental Disorders
Marilovtseva, E. V., Abdurazakov, A., Kurishev, A. O., Mikhailova, V. A., & Голимбет, В. Е. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199492 · Cited by 20
Epigenetic Targets in Schizophrenia Development and Therapy
Wawrzczak‐Bargieła, A., Bilecki, W., & Maćkowiak, M. (2023) · Brain Sciences · doi:10.3390/brainsci13030426 · Cited by 25
Bosia, M., Pigoni, A., & Cavallaro, R. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.976552 · Cited by 21
Gürel, Ç., Kuşçu, G. C., Yavaşoğlu, A., & Avcı, Ç. B. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.005 · Cited by 22
Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis?
Abdolmaleky, H., & Thiagalingam, S. (2011) · Epigenomics · doi:10.2217/epi.11.94 · Cited by 17
Johnstone, A. L., O’Reilly, J. J., Patel, A. J., Guo, Z., Andrade, N. S., Magistri, M., Nathanson, L., Esanov, R., Miller, B. H., Turecki, G., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.005 · Cited by 18
de Bartolomeis, A., Avvisati, L., Iasevoli, F., & Tomasetti, C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.034 · Cited by 17
Gavin, D. P., & Floreani, C. V. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801311-3.00005-6 · Cited by 17
Mehta, R., Singh, A., Bókkon, I., & Mallick, B. N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150414185737 · Cited by 18
Lin, T.-B., Lai, C., Hsieh, M., Ho, Y., Wang, H.-H., Yang, P., Cheng, J., Chen, G., Ng, S., & Peng, H. (2020) · Pain · doi:10.1097/j.pain.0000000000001898 · Cited by 18
Examining the contribution of histone modification to sex differences in learning and memoryPreprint
Keiser, A. A., & Wood, M. A. (2019) · Learning & Memory · doi:10.1101/lm.048850.118 · Cited by 17
Chromosomal Conformations and Epigenomic Regulation in Schizophrenia
Rajarajan, P., Jiang, Y., Kassim, B. S., & Akbarian, S. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.022 · Cited by 16
Self-citationHattori, Y., Matsuda, S., Baba, R., Matsumiya, K., Iwasaki, S., Constantinescu, C. C., Morley, T. J., Carroll, V. M., Papin, C., Gouasmat, A., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01937 · Cited by 16
A Chromatin Assay for Human Brain Tissue
Matevossian, A., & Akbarian, S. (2008) · Journal of Visualized Experiments · doi:10.3791/717 · Cited by 16
Self-citationAn epigenomics approach to individual differences and its translation to neuropsychiatric conditions
Sweatt, J. D., & Tamminga, C. A. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.3/dsweatt · Cited by 15
Metadata
- Authors
- Huang, H.-S., Matevossian, A., Whittle, C., Kim, S. Y., Schumacher, A., Baker, S. P., & Akbarian, S.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Baylor College of Medicine (US)
- Corresponding author
- Akbarian, Schahram
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-10-17
- Volume
- 27
- Issue
- 42
- Pages
- 11254-11262
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6673022
- OpenAlex
- W2124607109
- Cited by
- 352
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 19 · 2021: 15 · 2020: 13 · 2019: 12 · 2018: 15 · 2017: 10 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 25
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute of Mental Health
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- schizophrenia, prefrontal cortex, MLL1, histone H3 lysine 4 methylation, GABAergic neurons, GAD1, promoter, chromatin remodeling, clozapine, dopamine D2/D3 receptors, sex differences, brain development
- MeSH terms
- Adult, Animals, Cells, Cultured, Child, Female, gamma-Aminobutyric Acid, Glutamate Decarboxylase, Histones, Humans, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Promoter Regions, Genetic, Histone-Lysine N-Methyltransferase, Schizophrenia, Prefrontal Cortex, DNA Methylation, Mice, Rats, Myeloid-Lymphoid Leukemia Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
